Please login to the form below

Not currently logged in
Email:
Password:

Abbott and Zydus emerging markets deal

Abbott has entered into an agreement with India's Zydus Cadila relating to a portfolio of products that it will commercialise in 15 emerging markets

Abbott has entered into a licensing and supply agreement with India-based Zydus Cadila. The deal relates to a portfolio containing at least 24 Zydus products, which Abbott will commercialise in 15 key emerging markets where Abbott already has a strong and growing presence.

As part of the agreement, more than 40 additional Zydus products could be added to the collaboration deal. The partnership covers medicines for pain, cancer and cardiovascular, neurological and respiratory diseases. Product launches are expected to commence in early 2012.

Abbott has also created a stand-alone Established Products Division (EPD) that will concentrate on expanding access to non-US markets, particularly emerging markets, for Abbott's established pharmaceutical products.

"Our new Established Products Division, with $5bn in sales, wll focus on expanding our presence and product offerings in the world's fastest-growing emerging markets," said Olivier Bohuon, executive vice president, Pharmaceutical Products Group, Abbott.

Abbott has a large portfolio of branded generics, which the company has built up over the past 10 years, Abbott's acquisition of Solvay earlier this year helped the company to gain significant critical mass in key emerging markets.

12th May 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...
Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...